Simplex Trading, LLC Kura Oncology, Inc. Transaction History

Simplex Trading, LLC

$175 Billion
Q2 2025

A detailed history of Simplex Trading, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 4,209 shares of KURA stock, worth $43,941. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,209

Previous 14,863 71.68%

Holding current value

$43,941

Previous $98,000 75.51%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$5.55 - $6.92 $59,129 - $73,725	-10,654 Reduced 71.68%	4,209 $24,000
Q1 2025 May 12, 2025	BUY	$6.6 - $9.05 $98,095 - $134,510	14,863 New	14,863 $98,000
Q1 2024 Apr 25, 2024	BUY	$13.42 - $23.53 $217,417 - $381,209	16,201 Added 214.72%	23,746 $506,000
Q4 2023 Feb 02, 2024	BUY	$7.58 - $14.38 $55,561 - $105,405	7,330 Added 3409.3%	7,545 $108,000
Q3 2023 Nov 01, 2023	SELL	$8.44 - $11.86 $35,684 - $50,144	-4,228 Reduced 95.16%	215 $1,000
Q2 2023 Aug 04, 2023	BUY	$9.62 - $13.99 $42,741 - $62,157	4,443 New	4,443 $47,000
Q3 2021 Oct 28, 2021	SELL	$15.42 - $21.72 $24,625 - $34,686	-1,597 Reduced 23.95%	5,070 $110,000
Q2 2021 Aug 12, 2021	BUY	$20.85 - $29.88 $82,753 - $118,593	3,969 Added 147.11%	6,667 $139,000
Q1 2021 Apr 26, 2021	SELL	$24.75 - $39.14 $372,438 - $588,978	-15,048 Reduced 84.8%	2,698 $76,000
Q4 2020 Feb 02, 2021	BUY	$29.0 - $41.62 $514,634 - $738,588	17,746 New	17,746 $579,000
Q3 2020 Oct 14, 2020	SELL	$16.3 - $30.64 $281,778 - $529,673	-17,287 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$7.95 - $18.81 $110,854 - $262,286	13,944 Added 417.11%	17,287 $281,000
Q1 2020 Apr 29, 2020	BUY	$6.45 - $14.04 $15,583 - $33,920	2,416 Added 260.63%	3,343 $33,000
Q4 2019 Feb 05, 2020	BUY	$12.97 - $15.94 $12,023 - $14,776	927 New	927 $12,000
Q2 2019 Jul 26, 2019	SELL	$14.71 - $19.79 $3,927 - $5,283	-267 Closed	0 $0
Q1 2019 Apr 18, 2019	SELL	$13.73 - $16.87 $141,844 - $174,283	-10,331 Reduced 97.48%	267 $0
Q4 2018 Jan 16, 2019	BUY	$10.6 - $17.49 $63,684 - $105,079	6,008 Added 130.89%	10,598 $148,000
Q3 2018 Oct 23, 2018	BUY	$16.65 - $21.85 $54,278 - $71,231	3,260 Added 245.11%	4,590 $80,000
Q2 2018 Jul 30, 2018	BUY	$14.8 - $18.8 $19,684 - $25,004	1,330 New	1,330 $24,000

Others Institutions Holding KURA

# of Institutions

200

Shares Held

80.6M

Call Options Held

53.6K

Put Options Held

42.8K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $698M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Kura Oncology, Inc. Transaction History